UnitedHealth Group (UNH) director reports 168-share stock grant in filing

Rhea-AI Filing Summary

UnitedHealth Group reported an insider equity transaction involving one of its directors. On 01/02/2026, the director received 168 shares of common stock, described as a regular quarterly compensation grant for board service. The shares were acquired at a stated price of $0, reflecting that they are part of non-cash director compensation rather than an open-market purchase.

Following this grant, the director beneficially owns 2,075 shares of UnitedHealth Group common stock directly and 3,800 shares indirectly through a trust. The filing records the transaction as an acquisition of common stock and confirms it is being reported by a single reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gil Kristen

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		168(1)	A	$0	2,075	D
Common Stock								3,800	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Kristen L. Gil	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UnitedHealth Group (UNH) disclose in this Form 4?

The filing shows a director of UnitedHealth Group acquired 168 shares of common stock on 01/02/2026 as part of regular quarterly director compensation.

At what price were the 168 UnitedHealth Group (UNH) shares acquired?

The 168 shares of UnitedHealth Group common stock were acquired at a stated price of $0, reflecting a stock grant as compensation rather than a market purchase.

How many UnitedHealth Group (UNH) shares does the director own after this transaction?

After the transaction, the director beneficially owns 2,075 shares of UnitedHealth Group common stock directly and 3,800 shares indirectly through a trust.

What is the reason given for the 168-share grant at UnitedHealth Group (UNH)?

The filing explains that the 168 shares of common stock represent shares granted as regular quarterly compensation for service as a director of UnitedHealth Group.

Who signed the UnitedHealth Group (UNH) Form 4 for this director stock grant?

The Form 4 was signed by Faraz A. Choudhry acting as Attorney-in-Fact for Kristen L. Gil, the reporting director.

Is this UnitedHealth Group (UNH) Form 4 filed by one reporting person or multiple?

The document indicates that the Form 4 is filed by one reporting person, rather than a joint or group filing.